MRK vs LLY
Merck & Co. vs Eli Lilly and Company — AI-powered side-by-side comparison
| Metric | MRK | LLY |
|---|---|---|
| AI Score | 56 | 63 |
| Price | $123.48 | $1,188.57 |
| P/E Ratio | 34.71× | 45.52× |
| ROE | 17.9% | 101.3% |
| Revenue Growth YoY | 2.9% | 47.4% |
| Gross Margin | 78.1% | 82.8% |
| Debt / Equity | 0.94× | 1.60× |
| Dividend Yield | 2.7% | 0.6% |
| RSI (14) | 45.9 | 51.0 |
| Beta | 0.21 | 0.5022 |
| Expected Upside | +0.4% | — |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
MRK Full Analysis
LLY Full Analysis